NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Enzymatica AB (ST: ENZY)
ENZY Technical Analysis
5
As on 1st Apr 2025 ENZY STOCK Price closed @ 4.29 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 3.08 & Strong Buy for SHORT-TERM with Stoploss of 3.76 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ENZYSTOCK Price
Open | 4.50 | Change | Price | % |
High | 4.54 | 1 Day | -0.13 | -2.94 |
Low | 4.15 | 1 Week | -0.55 | -11.36 |
Close | 4.29 | 1 Month | 2.59 | 152.35 |
Volume | 138102 | 1 Year | 0.83 | 23.99 |
52 Week High 4.90 | 52 Week Low 1.36 |
ST Sweden Most Active Stocks
ATORX | 0.01 | 0.00% |
FING-B | 0.01 | 0.00% |
QUIA | 0.01 | % |
LUNE | 21.97 | 6.65% |
SBB-B | 3.46 | 2.37% |
QLINEA | 0.04 | 0.00% |
FNOX | 85.70 | -1.47% |
XBRANE | 0.21 | 0.00% |
ONCO | 1.66 | 12.16% |
EURA | 0.01 | 0.00% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
ENZY Daily Charts |
ENZY Intraday Charts |
Whats New @ Bazaartrend |
ENZY Free Analysis |
|
ENZY Important Levels Intraday
RESISTANCE | 5.04 |
RESISTANCE | 4.80 |
RESISTANCE | 4.65 |
RESISTANCE | 4.50 |
SUPPORT | 4.08 |
SUPPORT | 3.93 |
SUPPORT | 3.78 |
SUPPORT | 3.54 |
ENZY Forecast April 2025
4th UP Forecast | 6.89 |
3rd UP Forecast | 6.06 |
2nd UP Forecast | 5.54 |
1st UP Forecast | 5.03 |
1st DOWN Forecast | 3.55 |
2nd DOWN Forecast | 3.04 |
3rd DOWN Forecast | 2.52 |
4th DOWN Forecast | 1.69 |
ENZY Weekly Forecast
4th UP Forecast | 6.22 |
3rd UP Forecast | 5.60 |
2nd UP Forecast | 5.22 |
1st UP Forecast | 4.84 |
1st DOWN Forecast | 3.75 |
2nd DOWN Forecast | 3.36 |
3rd DOWN Forecast | 2.98 |
4th DOWN Forecast | 2.36 |
ENZY Forecast2025
4th UP Forecast | 12.21 |
3rd UP Forecast | 9.67 |
2nd UP Forecast | 8.1 |
1st UP Forecast | 6.53 |
1st DOWN Forecast | 2.05 |
2nd DOWN Forecast | 0.48 |
3rd DOWN Forecast | -1.09 |
4th DOWN Forecast | -3.63 |
Enzymatica AB ( ST Sweden Symbol : ENZY )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ENZY Other Details
Segment | EQ | |
Market Capital | 1591793792.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
ENZY Address
![]() |
ENZY Latest News
ENZY Business Profile
Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases in Sweden and internationally. Its product includes ColdZyme mouth spray, which prevents cold and reduces the duration of illness. The company also provides ColdZyme mouth spray under the PreCold name in Iceland; ViruProtect name in Austria and Belgium; ColdGuard name in South Africa; Zerinol Virus Defense in Italy; and Psysiomer Stop Virus in France. It also offers STADAProtect, a mouth spray to protect and care oral cavity, as well as enzyme formulations. Enzymatica AB was incorporated in 2007 and is based in Lund, Sweden. Address: Ideon Science Park, Lund, Sweden, 223 70
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service